• Explore /
  • Poster
  • / Impact of body mass index on treatment and outcomes in patients with early hormone receptor-positive breast cancer receiving endocrine therapy with or without palbociclib in the PALLAS trial.

Impact of body mass index on treatment and outcomes in patients with early hormone receptor-positive breast cancer receiving endocrine therapy with or without palbociclib in the PALLAS trial.

Abstract Video & Slides Poster

Authors

Georg Pfeiler

Georg Pfeiler

Department of Obstetrics and Gynecology and Center for Breast Health, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria

Georg Pfeiler , Dominik Hlauschek , Erica L. Mayer , Christine Deutschmann , Stephanie Kacerovsky-Strobl , Miguel Martin , Jane Lowe Meisel , Nicholas Zdenkowski , Sibylle Loibl , Marija Balic , Haeseong Park , Aleix Prat , Claudine Isaacs , Jana Machacek-Link , Celine Schurmans , Kathy Puyana Theall , Christian Fesl , Amylou C. Dueck , Angela DeMichele , Michael Gnant

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Breast Cancer—Local/Regional/Adjuvant

Track

Breast Cancer

Sub Track

Adjuvant Therapy

Clinical Trial Registration Number

NCT02513394

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 518)

DOI

10.1200/JCO.2022.40.16_suppl.518

Abstract #

518

Poster Bd #

290

Abstract Disclosures

Similar Posters

First Author: Celine Yeh

First Author: Frederik Marmé

First Author: Marina Maglakelidze

First Author: Rachel A. Freedman